17-39707009-G-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 1P and 10B. PVS1_SupportingBP6_ModerateBS1BS2
The ENST00000578199.5(ERBB2):c.3G>T(p.Met1?) variant causes a start lost change. The variant allele was found at a frequency of 0.000164 in 1,594,508 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.00012 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00017 ( 2 hom. )
Consequence
ERBB2
ENST00000578199.5 start_lost
ENST00000578199.5 start_lost
Scores
4
10
4
Clinical Significance
Conservation
PhyloP100: 5.84
Publications
11 publications found
Genes affected
ERBB2 (HGNC:3430): (erb-b2 receptor tyrosine kinase 2) This gene encodes a member of the epidermal growth factor (EGF) receptor family of receptor tyrosine kinases. This protein has no ligand binding domain of its own and therefore cannot bind growth factors. However, it does bind tightly to other ligand-bound EGF receptor family members to form a heterodimer, stabilizing ligand binding and enhancing kinase-mediated activation of downstream signalling pathways, such as those involving mitogen-activated protein kinase and phosphatidylinositol-3 kinase. Allelic variations at amino acid positions 654 and 655 of isoform a (positions 624 and 625 of isoform b) have been reported, with the most common allele, Ile654/Ile655, shown here. Amplification and/or overexpression of this gene has been reported in numerous cancers, including breast and ovarian tumors. Alternative splicing results in several additional transcript variants, some encoding different isoforms and others that have not been fully characterized. [provided by RefSeq, Jul 2008]
ERBB2 Gene-Disease associations (from GenCC):
- Hirschsprung diseaseInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- lung cancerInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- glioma susceptibility 1Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
- visceral neuropathy, familial, 2, autosomal recessiveInheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -9 ACMG points.
PVS1
Start lost variant, no pathogenic variants between lost start and next in-frame start position. Next in-frame start position is after 15 codons. Genomic position: 39707049. Lost 0.024 part of the original CDS.
BP6
Variant 17-39707009-G-T is Benign according to our data. Variant chr17-39707009-G-T is described in ClinVar as Likely_benign. ClinVar VariationId is 134076.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.000125 (19/152332) while in subpopulation SAS AF = 0.00393 (19/4830). AF 95% confidence interval is 0.00258. There are 0 homozygotes in GnomAd4. There are 14 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 19 Unknown,AD gene.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000125 AC: 19AN: 152214Hom.: 0 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
19
AN:
152214
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000345 AC: 80AN: 231886 AF XY: 0.000548 show subpopulations
GnomAD2 exomes
AF:
AC:
80
AN:
231886
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000168 AC: 243AN: 1442176Hom.: 2 Cov.: 30 AF XY: 0.000265 AC XY: 190AN XY: 716744 show subpopulations
GnomAD4 exome
AF:
AC:
243
AN:
1442176
Hom.:
Cov.:
30
AF XY:
AC XY:
190
AN XY:
716744
show subpopulations
African (AFR)
AF:
AC:
0
AN:
32712
American (AMR)
AF:
AC:
0
AN:
42650
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
25100
East Asian (EAS)
AF:
AC:
0
AN:
38096
South Asian (SAS)
AF:
AC:
226
AN:
83384
European-Finnish (FIN)
AF:
AC:
0
AN:
52654
Middle Eastern (MID)
AF:
AC:
0
AN:
5710
European-Non Finnish (NFE)
AF:
AC:
3
AN:
1102258
Other (OTH)
AF:
AC:
14
AN:
59612
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
11
23
34
46
57
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.000125 AC: 19AN: 152332Hom.: 0 Cov.: 32 AF XY: 0.000188 AC XY: 14AN XY: 74486 show subpopulations
GnomAD4 genome
AF:
AC:
19
AN:
152332
Hom.:
Cov.:
32
AF XY:
AC XY:
14
AN XY:
74486
show subpopulations
African (AFR)
AF:
AC:
0
AN:
41576
American (AMR)
AF:
AC:
0
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3472
East Asian (EAS)
AF:
AC:
0
AN:
5182
South Asian (SAS)
AF:
AC:
19
AN:
4830
European-Finnish (FIN)
AF:
AC:
0
AN:
10628
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
0
AN:
68030
Other (OTH)
AF:
AC:
0
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
43
Asia WGS
AF:
AC:
2
AN:
3478
ClinVar
Significance: Likely benign
Submissions summary: Benign:1Other:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Mar 11, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified Other:1
Sep 19, 2013
ITMI
Significance:not provided
Review Status:no classification provided
Collection Method:reference population
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Uncertain
T
BayesDel_noAF
Pathogenic
DANN
Uncertain
DEOGEN2
Uncertain
.;.;.;.;.;T;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
.;D;D;D;D;D;D
MetaRNN
Benign
T;T;T;T;T;T;T
MetaSVM
Uncertain
T
MutationAssessor
Benign
.;.;.;.;.;L;.
PhyloP100
PrimateAI
Uncertain
T
PROVEAN
Benign
.;.;N;N;.;N;.
REVEL
Uncertain
Sift
Uncertain
.;.;D;T;.;D;.
Sift4G
Pathogenic
D;D;D;T;D;T;D
Polyphen
0.34, 0.31, 0.065
.;B;.;B;.;B;.
Vest4
MutPred
0.50
.;.;.;.;Loss of ubiquitination at K32 (P = 0.0598);Loss of ubiquitination at K32 (P = 0.0598);.;
MVP
MPC
0.50
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.